A Study in Healthy Men to Test How Well Different Doses of BI 3731579 Are Tolerated

NCT06429137 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 3731579
DRUG: Matching placebo to BI 3731579

Sponsor

Boehringer Ingelheim